Magnolia Neurosciences
Magnolia Neurosciences Corporation is a drug discovery and development company focused on the creation of a novel class of neuroprotective medicines. The company was launched by a $31 million Series A...load more
Magnolia Neurosciences's Basic Information
Industry
Headquarters
New York, United States
Founded Year
2018
Headcount
2 - 10 ( View All )
Specialties
neuroprotectiveneurodegenerativesmall molecule therapeutics
Magnolia Neurosciences's Competitors
Employee Insights
Magnolia Neurosciences's Top Employees
Brett Abrahams
Executive Vice-President, Research & Development
Phone Email
Jennifer Schmidt
Associate Director, Research AND Development
Phone Email
Frequently Asked Questions Regarding Magnolia Neurosciences
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts